Details of the Drug
General Information of Drug (ID: DMD8FS5)
| Drug Name |
US10034861, Example 165
|
|||||
|---|---|---|---|---|---|---|
| Synonyms | SCHEMBL19762492; BDBM279134; US10034861, Example 165; N-[[1-(difluoromethyl)pyrazol-4-yl]methyl]-5-(2-ethoxy-3-pyridyl)-1-isopropyl-3-methyl-pyrazolo[4,3-b]pyridin-7-amine | |||||
| Drug Type |
Small molecular drug
|
|||||
| Structure |
![]() |
|||||
| 3D MOL | 2D MOL | |||||
| #Ro5 Violations (Lipinski): 3 | Molecular Weight (mw) | 561.6 | ||||
| Logarithm of the Partition Coefficient (xlogp) | 5.2 | |||||
| Rotatable Bond Count (rotbonds) | 11 | |||||
| Hydrogen Bond Donor Count (hbonddonor) | 0 | |||||
| Hydrogen Bond Acceptor Count (hbondacc) | 9 | |||||
| Chemical Identifiers |
|
|||||
| Cross-matching ID | ||||||
| Drug-Molecule Activity Atlas (DMA)NEW | Click to Jump to the Detailed DMA Information of This Drug | |||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||


